What is Terason?
Terason specializes in the development and production of portable ultrasound machines, catering to a wide array of medical applications. Their product portfolio features sophisticated models like the uSmart 3300 NexGen and uSmart 3200T, which integrate cutting-edge technologies such as Dynamic Depth Resolution and Enhanced Needle Visualization. These advanced systems are designed to improve diagnostic accuracy and operational efficiency for healthcare professionals across various specialties, including emergency medicine, cardiology, and musculoskeletal care. Terason also complements its hardware offerings with comprehensive educational programs and technical support, ensuring optimal utilization of its ultrasound technology.
How much funding has Terason raised?
Terason has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
What's next for Terason?
With the recent injection of capital, Terason is poised to accelerate its strategic initiatives. The large-scale, late-stage funding suggests a focus on scaling operations, expanding market reach, and potentially further research and development into next-generation ultrasound technology. This investment will likely enable Terason to solidify its competitive advantage in the portable medical imaging market and pursue new opportunities for growth and innovation in healthcare delivery.
See full Terason company page
